These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9349803)
1. Disomy and disease resolved? Hastie N Nature; 1997 Oct; 389(6653):785, 787. PubMed ID: 9349803 [No Abstract] [Full Text] [Related]
2. p57KIP2 targeted disruption and Beckwith-Wiedemann syndrome: is the inhibitor just a contributor? Swanger WJ; Roberts JM Bioessays; 1997 Oct; 19(10):839-42. PubMed ID: 9363677 [TBL] [Abstract][Full Text] [Related]
3. The two-domain hypothesis in Beckwith-Wiedemann syndrome. Feinberg AP J Clin Invest; 2000 Sep; 106(6):739-40. PubMed ID: 10995782 [No Abstract] [Full Text] [Related]
4. Overgrowth syndromes and genomic imprinting: from mouse to man. Li M; Squire JA; Weksberg R Clin Genet; 1998 Mar; 53(3):165-70. PubMed ID: 9630066 [TBL] [Abstract][Full Text] [Related]
5. Wiedemann-Beckwith syndrome: genomic imprinting revisited. Weksberg R Am J Med Genet; 1994 Aug; 52(2):235-6. PubMed ID: 7802017 [No Abstract] [Full Text] [Related]
6. Analysis of CDKN1C in Beckwith Wiedemann syndrome. Algar E; Brickell S; Deeble G; Amor D; Smith P Hum Mutat; 2000; 15(6):497-508. PubMed ID: 10862080 [TBL] [Abstract][Full Text] [Related]
11. Dads and disomy and disease. Little M; Van Heyningen V; Hastie N Nature; 1991 Jun; 351(6328):609-10. PubMed ID: 2052085 [No Abstract] [Full Text] [Related]
12. CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance. Algar EM; Deeble GJ; Smith PJ J Med Genet; 1999 Jul; 36(7):524-31. PubMed ID: 10424812 [TBL] [Abstract][Full Text] [Related]
13. Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome. Grandjean V; Smith J; Schofield PN; Ferguson-Smith AC Proc Natl Acad Sci U S A; 2000 May; 97(10):5279-84. PubMed ID: 10779549 [TBL] [Abstract][Full Text] [Related]
14. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Sun FL; Dean WL; Kelsey G; Allen ND; Reik W Nature; 1997 Oct; 389(6653):809-15. PubMed ID: 9349812 [TBL] [Abstract][Full Text] [Related]
15. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor. Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Lausch E; Reutzel D; Fees S; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B Nat Genet; 2005 Aug; 37(8):785-6; author reply 786-7. PubMed ID: 16049499 [No Abstract] [Full Text] [Related]
17. Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome. Reik W; Maher ER Trends Genet; 1997 Aug; 13(8):330-4. PubMed ID: 9260520 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Igf2 imprinting in development and disease. Reik W; Bowden L; Constancia M; Dean W; Feil R; Forné T; Kelsey G; Maher E; Moore T; Sun FL; Walter J Int J Dev Biol; 1996; Suppl 1():53S-54S. PubMed ID: 9087693 [No Abstract] [Full Text] [Related]
19. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby. Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708 [TBL] [Abstract][Full Text] [Related]